Diabetes care market encompasses of technologies, devices and therapeutics in relative to diabetes. There has been a substantial increase in the amount of diabetes cases internationally over the last few years. Currently, about millions of people are in misery because of obesity, which is a key reason for increase of diabetes in people. Key Players profiled in the report include GlaxoSmithKline, Novo Nordisk, Roche, Medtronic and etc. Novo Nordisk is a leading global provider of diabetes products. The company also has a headship spot in haemostasis management, growth hormone therapy and hormone replacement therapy. The company progresses, manufactures and markets its medical devices and technologies to hospitals, doctors, researchers, scientists and patients in approximately 160 countries.
- Hormone replacement therapy
- Blood glucose monitoring system